Zacks Research Cuts Earnings Estimates for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Analysts at Zacks Research decreased their Q1 2025 earnings estimates for shares of Teladoc Health in a research note issued on Wednesday, March 12th. Zacks Research analyst R. Department now forecasts that the health services provider will post earnings of ($0.40) per share for the quarter, down from their previous forecast of ($0.38). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health’s Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($1.08) EPS, Q2 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.11) EPS and FY2026 earnings at ($0.90) EPS.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.

Several other research firms also recently weighed in on TDOC. Piper Sandler dropped their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Bank of America boosted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Oppenheimer dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Finally, Royal Bank of Canada boosted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and an average price target of $11.26.

Teladoc Health Stock Down 5.3 %

NYSE:TDOC opened at $8.40 on Monday. The company has a market cap of $1.46 billion, a PE ratio of -1.46 and a beta of 1.27. Teladoc Health has a twelve month low of $6.76 and a twelve month high of $15.68. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company’s 50 day moving average is $10.51 and its two-hundred day moving average is $9.74.

Institutional Trading of Teladoc Health

A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after acquiring an additional 1,029,829 shares during the period. Point72 Asset Management L.P. raised its position in Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock worth $101,625,000 after acquiring an additional 2,813,568 shares during the period. Renaissance Technologies LLC raised its position in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock worth $51,582,000 after acquiring an additional 763,265 shares during the period. Geode Capital Management LLC raised its position in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider’s stock worth $35,894,000 after acquiring an additional 22,664 shares during the period. Finally, Maple Rock Capital Partners Inc. raised its position in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.